Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Ochsner Journal|March 28, 2013
Intracellular Enhanced Cyan Fluorescent Protein/Angiotensin II Does Not Modify Angiotensinogen Accumulation in Transgenic MiceAkannsha Singh, Jason Vitko, Richard N Re, et al.American Journal of Physiology. Cell Physiology|August 5, 2011
Expression of a naturally occurring angiotensin AT(1) receptor cleavage fragment elicits caspase-activation and apoptosisJulia L Cook, Akannsha Singh, Dawn DeHaro, et al.Nature Clinical Practice. Cardiovascular Medicine|September 26, 2007
Mechanisms of disease: Intracrine physiology in the cardiovascular systemRichard N Re, Julia L CookJournal of the American Society of Hypertension : JASH|September 6, 2011
Noncanonical intracrine actionRichard N Re, Julia L CookAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|December 16, 2011
Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse modelJulia L Cook, Richard N ReJournal of Clinical Pharmacology|January 29, 2008
The basis of an intracrine pharmacologyRichard N Re, Julia L CookAmerican Journal of Physiology. Heart and Circulatory Physiology|July 13, 2010
The mitochondrial component of intracrine actionRichard N Re, Julia L CookAmerican Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine actionRichard N Re, Julia L CookAmerican Journal of Physiology. Heart and Circulatory Physiology|June 17, 2008
The physiological basis of intracrine stem cell regulationRichard N Re, Julia L CookPageof 7